Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Phenotype |hepatocellular carcinoma
Sentences 268
PubMedID- 24570914 Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis b virus infection.
PubMedID- 23661457 Evaluation of a histocompatibility antigen related to hepatitis b virus in patients with hepatocellular carcinoma in the western brazilian amazon.
PubMedID- 23099187 Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study.
PubMedID- 20731020 hepatocellular carcinoma in patients with chronic hepatitis c virus infection without cirrhosis.
PubMedID- 25873850 The present case was a young man, a known case of chronic hepatitis b with multiple recurrent hepatocellular carcinoma, who presented with clinical sepsis and jaundice.
PubMedID- 24745029 We evaluated clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-b non-c (nbnc) hepatocellular carcinoma (hcc) patients with comparison to hepatitis b or c virus, paying attention to relationship between alcohol consumption and histopathological findings.
PubMedID- 26064099 Three patients (27%) had other extracolonic cancers or hematologic malignancies: one with hepatocellular carcinoma (hcc) associated with chronic hepatitis b, one with lung cancer, and one with myelodysplastic syndrome (mds).
PubMedID- 22957141 End-stage liver diseases as well as hepatocellular carcinoma attributable to chronic hepatitis c are increasingly serious problems2.
PubMedID- 23306849 The frequency of hepatocellular carcinoma in patients with autoimmune hepatitis and cirrhosis is 1-9 %, and annual occurrence in patients with cirrhosis is 1.1-1.9 %.
PubMedID- 22231575 Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis b virus infection.
PubMedID- 26421022 The objective of this study was to investigate risk factors for intrahepatic recurrence after resection of hepatocellular carcinoma, especially in patients with hepatitis b virus infection.
PubMedID- 22271485 Statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection.
PubMedID- 24367218 Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus.
PubMedID- 22555181 Background: the extent of the effect of antiviral therapy and its predictors in preventing hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c (chc) or b (chb) remain unclear.
PubMedID- 25616940 Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis b virus.
PubMedID- 22819017 hepatocellular carcinomas have been associated with hepatitis virus infections and excessive hepatic iron in man; however, no association was established between this tumour and viral infection or hepatic iron storage disease in the present case.
PubMedID- 22363173 We observed a strong correlation between hepatic 8-oxodg staining and serum ferritin levels, suggesting the iron content to be a strong mediator of oxidative stress and iron reduction to reduce the incidence of hepatocellular carcinoma in patients with chronic hepatitis c [57, 58].
PubMedID- 20207771 Results: alpha-fetoprotein (afp) may be used in conjunction with abdominal ultrasound for early detection of hepatocellular carcinoma (hcc) in patients with chronic hepatitis or cirrhosis associated with hepatitis b or c virus infection.
PubMedID- 24485003 Thus, the present study was designed to investigate the protective effect of s-adenosylmethionine (same) on hiri, especially for patients with hepatocellular carcinoma (hcc) associated with chronic hepatitis b virus (hbv) infection and cirrhosis.
PubMedID- 23483081 Differential expression of wnt pathway genes in sporadic hepatocellular carcinomas infected with hepatitis b virus identified with oligoge arrays.
PubMedID- 23236406 The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis b virus infection and cirrhosis.
PubMedID- 23065464 Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects.
PubMedID- 25015850 Case report: we have reported a patient who developed de novo uc after olt to treat liver cirrhosis and hepatocellular carcinoma associated with hepatitis b virus (hbv) infection.
PubMedID- 23237253 The article reviewed here reports on the prognostic role of liver stiffness as measured by transient elastography and other noninvasive methods in the prediction of clinical decompensation and hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 23125843 The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005).
PubMedID- 25442807 An adolescent female having hepatocellular carcinoma associated with hepatitis b virus genotype h with a deletion mutation in the pre-s2 region.
PubMedID- 24930484 Here, we assessed the prognostic performance of lsps in predicting the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb).
PubMedID- 25299117 Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis b and c viruses.
PubMedID- 25279176 Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis b virus infection: a field survey between 2000 and 2012.
PubMedID- 25921128 Cyp2c19 genotype could be a predictive factor for aggressive manifestations of hepatocellular carcinoma related with chronic hepatitis b infection in thailand.
PubMedID- 21931376 Objectives: prospective studies of serum hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c are lacking.
PubMedID- 21253791 Overall, these data suggest that chemoprevention of hepatocellular carcinoma in patients with chronic hepatitis c is an achievable objective.
PubMedID- 21103209 Three years earlier, the patient had undergone transcatheter arterial embolization and radiofrequency treatment based on a diagnosis of hepatocellular carcinoma due to hepatitis b by another doctor.
PubMedID- 22675319 The expression of dlk1-dio3 mirna was examined in 97 patients with hepatocellular carcinoma (hcc) associated with hepatitis b infection.
PubMedID- 24248733 Microrna-196a-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 24081938 Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted.
PubMedID- 22236533 Similar to ulcerative colitis, 15% of gastrointestinal malignancies arise as a consequence of chronic microbial infections, as demonstrated by the raised chance of hepatocellular carcinoma in patients with chronic hepatitis, association between helycobacter pylori infection and higher gastric cancer risk, and increased chance of colon cancer in patients with inflammatory bowel disease [59].
PubMedID- 21910010 Aim: to compare clinical and radiological findings of newly diagnosed hepatocellular carcinomas (hccs) in patients with chronic hepatitis b virus (hbv) and chronic hepatitis c virus (hcv) infections.
PubMedID- 26293077 hepatocellular carcinoma in the setting of chronic hepatitis b virus infection: tumor recurrence and survival rates after liver transplantation.
PubMedID- 23280722 Il17a gene polymorphisms, serum il-17a and ige levels, and hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection.
PubMedID- 23426277 Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c.
PubMedID- 24632756 The serum level of vegf has potential to be a useful predictor of the presence of hepatocellular carcinoma in patients with hepatitis c virus (hcv)-related liver cirrhosis, while serum levels of afp and vegf can predict tumor type and vascular invasion, respectively25.
PubMedID- 25667487 Patients and methods: serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis c virus infection who underwent curative hepatectomy.
PubMedID- 21563203 Inactivation of klf6 is common in hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection, thereby abrogating its normal antiproliferative activity in liver cells.
PubMedID- 24583062 Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis b treated with entecavir vs lamivudine.
PubMedID- 23683438 Reported that mir-148a was upregulated in hepatitis b cells associated with hepatocellular carcinoma (hcc) [27].
PubMedID- 22439008 [10] stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection.
PubMedID- 23930133 Non-alcoholic fatty liver disease (nafld) is a common cause of chronic hepatitis that can lead to cirrhosis and hepatocellular carcinoma (1, 2).
PubMedID- 25521761 Here, we profiled the mutations and gene expressions of early and advanced hepatocellular carcinoma (hcc) related with hepatitis b-viral infection.
PubMedID- 23689989 Il28b minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis c virus infection.

Page: 1 2 3 4 5 6